80.69

1.61% -1.32

After Hours: 81.00 0.31 +0.38%

Cvs Health Corp (CVS)

Overview News Price History Option Chain Financials Why CVS Down? Discussions Forecast Stock Split Dividend History

Cvs Health Corp stock is traded at $80.69, with a volume of 7.29M. It is down -1.61% in the last 24 hours and up +9.80% over the past month. CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.

Previous Close:

$82.01

Open:

$82.06

24h Volume:

7.29M

Relative Volume:

0.93

Market Cap:

$103.41B

Revenue:

$402.11B

Net Income/Loss:

$1.73B

P/E Ratio:

58.32

EPS:

1.3835

Net Cash Flow:

$7.81B

1W Performance:

-0.36%

1M Performance:

+9.80%

6M Performance:

+2.72%

1Y Performance:

+20.25%

1-Day Range:

$80.40

$82.30

1-Week Range:

$80.40

$83.93

52-Week Range:

$58.35

$85.15

Cvs Health Corp Stock (CVS) Company Profile

Name

Cvs Health Corp

Sector

Healthcare (1106)

Industry

Healthcare Plans (12)

Phone

(401) 765-1500

Address

ONE CVS DR., WOONSOCKET

Employee

300,000

Twitter

@cvshealth

Next Earnings Date

2026-05-06

Latest SEC Filings

CVS's Discussions on Twitter

Compare CVS vs UNH, ELV, CI, HUM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CVS Cvs Health Corp	80.69	105.10B	402.11B	1.73B	7.81B	1.3835
UNH Unitedhealth Group Inc	363.87	336.72B	449.71B	12.81B	19.67B	13.24
ELV Elevance Health Inc	369.07	80.76B	200.42B	5.24B	6.45B	23.50
CI Cigna Group	275.66	73.90B	278.13B	6.74B	7.66B	23.60
HUM Humana Inc	239.53	28.57B	137.20B	1.15B	1.27B	9.3439

Cvs Health Corp Stock (CVS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-12-26	Upgrade	Bernstein	Mkt Perform → Outperform
Oct-14-25	Initiated	Goldman	Buy
Aug-18-25	Upgrade	UBS	Neutral → Buy
Aug-14-25	Upgrade	Robert W. Baird	Neutral → Outperform
Feb-13-25	Upgrade	Leerink Partners	Market Perform → Outperform
Feb-12-25	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Jan-30-25	Upgrade	Edward Jones	Hold → Buy
Dec-03-24	Upgrade	Deutsche Bank	Hold → Buy
Nov-18-24	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-10-24	Upgrade	Barclays	Equal Weight → Overweight
Oct-04-24	Upgrade	TD Cowen	Hold → Buy
May-30-24	Initiated	Robert W. Baird	Neutral
May-07-24	Downgrade	TD Cowen	Buy → Hold
May-02-24	Downgrade	UBS	Buy → Neutral
May-01-24	Downgrade	Cantor Fitzgerald	Overweight → Neutral
May-01-24	Downgrade	Leerink Partners	Outperform → Market Perform
Mar-06-24	Initiated	Barclays	Equal Weight
Feb-26-24	Initiated	Leerink Partners	Outperform
Dec-22-23	Initiated	HSBC Securities	Buy
Sep-19-23	Upgrade	Evercore ISI	In-line → Outperform
Sep-12-23	Upgrade	Wolfe Research	Peer Perform → Outperform
Aug-18-23	Downgrade	Edward Jones	Buy → Hold
May-26-23	Initiated	Piper Sandler	Overweight
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line
Nov-23-22	Resumed	Morgan Stanley	Overweight
Jun-17-22	Initiated	Loop Capital	Buy
May-27-22	Downgrade	Bernstein	Outperform → Mkt Perform
Mar-29-22	Downgrade	Deutsche Bank	Buy → Hold
Feb-11-22	Downgrade	Raymond James	Strong Buy → Outperform
Dec-14-21	Initiated	Goldman	Buy
Dec-01-21	Initiated	Seaport Research Partners	Buy
May-19-21	Initiated	Wells Fargo	Equal Weight
Mar-17-21	Downgrade	Guggenheim	Buy → Neutral
Jan-08-21	Upgrade	Jefferies	Hold → Buy
Sep-17-20	Initiated	Piper Sandler	Overweight
Jul-01-20	Initiated	SVB Leerink	Mkt Perform
May-14-20	Upgrade	Credit Suisse	Neutral → Outperform
Sep-27-19	Resumed	RBC Capital Mkts	Outperform
Sep-12-19	Initiated	Deutsche Bank	Buy
Jun-05-19	Upgrade	Standpoint Research	Hold → Buy
Apr-29-19	Downgrade	Credit Suisse	Outperform → Neutral
Apr-18-19	Initiated	Guggenheim	Buy
Apr-15-19	Downgrade	Oppenheimer	Outperform → Perform
Apr-10-19	Reiterated	BofA/Merrill	Buy
Mar-13-19	Initiated	Bernstein	Outperform
Feb-20-19	Downgrade	Wells Fargo	Outperform → Market Perform
Jan-17-19	Initiated	UBS	Buy
Dec-18-18	Initiated	Barclays	Overweight
Nov-29-18	Resumed	Goldman	Neutral
Nov-28-18	Initiated	Evercore ISI	Outperform
Oct-26-18	Resumed	Wolfe Research	Peer Perform
Jul-09-18	Upgrade	Citigroup	Neutral → Buy
Feb-27-18	Resumed	BofA/Merrill	Buy
Feb-13-18	Reiterated	Citigroup	Neutral

View All

Cvs Health Corp Stock (CVS) Latest News

02:28 AM

CVS Health earnings up next: Can Aetna turnaround deliver? By Investing.com - Investing.com Canada

02:28 AM

11:39 AM

CVS to favor biosimilars over J&J’s Stelara starting in July By Investing.com - Investing.com South Africa

11:39 AM

11:15 AM

CVS to expand biosimilar formulary adoptions to improve affordability, accessibility - Fierce Healthcare

11:15 AM

10:53 AM

Aetna Better Health® of Louisiana collaborates with Goodr to launch mobile food market and chronic care program - CVS Health

10:53 AM

09:50 AM

CVS to drop J&J's Stelara from its main formularies - Reuters

09:50 AM

08:40 AM

CVS Caremark expands biosimilar adoption - TipRanks

08:40 AM

May 04, 2026

Jim Cramer Says “I Think That CVS Will Give You a Good Quarter” - Insider Monkey

May 04, 2026

Fathom Secures Strategic Investment From CVS Health Ventures to Accelerate Enterprise-Wide Autonomous Coding - Yahoo Finance

May 04, 2026

CVS and Google Cloud build AI health partner to cut care stress, costs - Stock Titan

May 04, 2026

May 03, 2026

CVS Health partners with Google; launching health tech subsidiary - Chain Store Age

May 03, 2026

All Rhode Island CVS locations now accepting WIC benefits for infant formula - Providence Business News

May 03, 2026

US Bancorp DE Buys 13,440 Shares of CVS Health Corporation $CVS - MarketBeat

May 03, 2026

Hussman Strategic Advisors Inc. Makes New $3.33 Million Investment in CVS Health Corporation $CVS - MarketBeat

May 03, 2026

PFA Pension Forsikringsaktieselskab Takes $57.58 Million Position in CVS Health Corporation $CVS - MarketBeat

May 03, 2026

Leerink reiterates CVS Health stock rating on AI platform launch - Investing.com

May 03, 2026

Davis Selected Advisers Acquires 1,356,870 Shares of CVS Health Corporation $CVS - MarketBeat

May 02, 2026

Jim Cramer Makes Major Claim About CVS Corporation (CVS) - Insider Monkey

May 02, 2026

May 01, 2026

CVS Health Corp. stock underperforms Friday when compared to competitors - MarketWatch

May 01, 2026

Beyond medication: A whole person approach to lasting weight loss - CVS Health

May 01, 2026

CVS Health (CVS) Is Up 5.6% After Regulatory Tailwinds Boost Aetna And PBM Visibility – Has The Bull Case Changed? - Yahoo Finance

May 01, 2026

Jennison Associates LLC Has $110.78 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat

May 01, 2026

Danske Bank A S Has $73.68 Million Stock Position in CVS Health Corporation $CVS - MarketBeat

May 01, 2026

CVS Health Corporation $CVS Shares Sold by GC Wealth Management RIA LLC - MarketBeat

May 01, 2026

Apr 30, 2026

The Boulder Group Arranges Sale of CVS Pharmacy in the Houston MSA - Barchart.com

Apr 30, 2026

Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors - Yahoo Finance

Apr 30, 2026

Cigna beats estimates, raises outlook on lower medical costs - Modern Healthcare

Apr 30, 2026

CVS Q1 Earnings Preview: Health Services Likely to Lead Performance - Yahoo Finance

Apr 30, 2026

W.G. Shaheen & Associates DBA Whitney & Co Takes Position in CVS Health Corporation $CVS - MarketBeat

Apr 30, 2026

Vest Financial LLC Buys 13,561 Shares of CVS Health Corporation $CVS - MarketBeat

Apr 30, 2026

CVS Health Corp. Stock (US1266501006): Q1 2026 Earnings Release Scheduled for Today - AD HOC NEWS

Apr 30, 2026

M&T Bank Corp Decreases Stock Position in CVS Health Corporation $CVS - MarketBeat

Apr 30, 2026

Apr 29, 2026

Vanguard Capital Management (NYSE: CVS) reports 95.6M shares, 7.51% stake - Stock Titan

Apr 29, 2026

CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch

Apr 29, 2026

CVS Health Corp Stock (CVS) Closed Up by 3.28% on Apr 29: Drivers Behind the Movement - TradingKey

Apr 29, 2026

CVS Sees Active Options Trading Amid Market Developments - GuruFocus

Apr 29, 2026

CVS Health Corp. Hits Day High with Strong 3.34% Intraday Surge - Markets Mojo

Apr 29, 2026

CVS Pharmacy Makes Cold & Cough Relief Easier With Delivery Straight to Your Door - ACCESS Newswire

Apr 29, 2026

CVS Health (CVS) to Release Earnings on Wednesday - MarketBeat

Apr 29, 2026

Wealthfront Advisers LLC Has $16.85 Million Position in CVS Health Corporation $CVS - MarketBeat

Apr 29, 2026

Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know - Yahoo Finance

Apr 29, 2026

Mitsubishi UFJ Trust & Banking Corp Trims Stock Position in CVS Health Corporation $CVS - MarketBeat

Apr 29, 2026

Pictet Asset Management Holding SA Has $65.93 Million Stock Position in CVS Health Corporation $CVS - MarketBeat

Apr 29, 2026

Apr 28, 2026